Last quarter (Q4 2022), Xeros Technology's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Xeros Technology's net income was £―. See Xeros Technology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	£ 164.00K	£ 474.00K	£ 385.00K	£ 1.81M	£ 2.69M
Cost of Revenue	-	£ 80.00K	£ 193.00K	£ 434.00K	£ 2.13M	£ 7.90M
Gross Profit	-	£ 84.00K	£ 281.00K	£ -49.00K	£ -311.00K	£ -5.21M
Operating Expense	-	£ 7.44M	£ 7.07M	£ 7.60M	£ 15.20M	£ 23.65M
Operating Income	-	£ -7.35M	£ -6.79M	£ -7.64M	£ -15.51M	£ -28.86M
Net Non Operating Interest Income Expense	-	£ -14.00K	£ -14.00K	£ 3.00K	£ -1.44M	£ 134.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	£ -7.45M	£ -6.93M	£ -7.63M	£ -18.53M	£ -28.45M
Tax Provision	-	£ -515.00K	£ -492.00K	£ -698.00K	£ -898.00K	£ -1.01M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ -6.93M	£ -6.44M	£ -6.97M	£ -20.64M	£ -29.37M
Basic EPS	-	£ -0.14	£ -0.27	£ -0.45	£ -6.53	£ -26.10
Diluted EPS	-	£ -0.14	£ -0.27	£ -0.45	£ -6.53	£ -26.10
Basic Average Shares	-	£ 48.53M	£ 24.27M	£ 15.45M	£ 3.16M	£ 1.13M
Diluted Average Shares	-	£ 48.53M	£ 24.27M	£ 15.45M	£ 3.16M	£ 1.13M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	£ -0.45	£ -6.13	£ -19.36
Reported Normalized Diluted E P S	-	-	-	£ -0.45	£ -6.13	£ -19.36
Rent Expense Supplemental	-	-	-	£ 40.00K	£ 10.00K	£ 431.00K
Total Expenses	-	£ 7.52M	£ -7.26M	£ 8.03M	£ 17.33M	£ 31.55M
Net Income From Continuing And Discontinued Operation	-	£ -6.93M	£ -6.44M	£ -6.97M	£ -20.64M	£ -29.37M
Normalized Income	-	£ -7.90M	£ -7.28M	£ -7.00M	£ -16.34M	£ -25.02M
Interest Expense	-	-	-	£ 6.00K	£ 24.00K	£ 0.00
EBIT	-	£ -7.42M	£ -6.93M	£ -7.63M	£ -18.50M	£ -28.45M
EBITDA	-	£ -7.27M	£ -6.93M	£ -7.41M	£ -17.93M	£ -27.73M

Currency in GBP

Xeros Technology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing